How do local authorities and humanitarian agencies collaborate when refugees are in transit? An IIED-supported research project is looking at the transit refugee response in Croatia.
In Numbers
2.1 million affected people, of which 894,000 are children.
1.4 million people require humanitarian assistance.
806,000 people severely food insecure.
On October 6, 11 cases of Cholera were confirmed positive in one neighbourhood of the capital Sana’a. No confirmed cases have been reported in other locations in Yemen. UNICEF, together with WHO and Health authorities, have initiated a rapid response setting up a treatment centre as well as dispat...ching an investigation team to the affected neighbourhood. The source of infection was identified as water and commercial food contamination.
more
In Numbers
2.1 million affected people, of which 894,000 are children.
1.4 million people require humanitarian assistance.
806,000 people severely food insecure.
Nòt Oryantasyon pou Sipò Sante Mantal ak Sipò Siko-sosyal
Repons-Dijans pou Tranblemanntè Ayiti – Janvye 2010
IN NUMBERS
1.4 million people in need of humanitarian assistance
100 percent of crops damaged
75 percent of the population affected in the hardest-hit areas
USD 5.6 million still needed to support 300 000 people
The checklist tool described in this handbook is intended for EU/EEA public health authorities who need to assess the capacity for communicable disease prevention and control at migrant reception/detention centres hosting migrants for weeks/months (medium-term) in order to identify gaps and set prio...rities for development.
Using this tool, the aim is to monitor and support capacity development to prevent the onset and improve the management of communicable disease outbreaks at medium-term migration reception/detention centres, both on a day-to-day basis and in the event of a sudden influx of migrants.
more
Globalization and Health201612:63; DOI: 10.1186/s12992-016-0195-3
Economic Issues, Policies and Option for Action
The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them.